 FOSTER CITY, Calif., Sept. 20, 2021 GLOBE NEWSWIRE -- Vaxcyte, Inc. Nasdaq: PCVX, a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide, today announced it has appointed Annie Drapeau and Teri Loxam to its board of directors. In connection with these appointments, longtime board members Patrick Heron and Rob Hopfner have stepped down from the board. 